Tyenne - Tocilizumab-aazg Concentrate 400 mg / 20mL Injection 20 mL

Reference details for licensed healthcare facility review and verification.

Tocilizumab-aazg Concentrate NDC Family 65219-0594 Tocilizumab-aazg Concentrate 400 mg / 20mL

NDC 11	65219-0594-20
Product NDC	65219-0594
Generic Drug Name	Tocilizumab-aazg Concentrate
Brand Name	Tyenne
Manufacturer	Fresenius Kabi USA, LLC
Strength	400 mg / 20mL
Dosage Form	Injection
Drug Type	Intravenous
Package Quantity	1 Vial, Single-Dose
Package Description	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-594-20) / 20 mL in 1 VIAL, SINGLE-DOSE
Active Ingredients	Tocilizumab
Marketing Category	BLA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply current stock, manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Tocilizumab-aazg Concentrate 400 mg / 20mL Injection is tracked under NDC 65219-0594-20 and rolls up into product family 65219-0594. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 1 Vial, Single-Dose.
Manufacturer: Fresenius Kabi USA, LLC.
Dosage form: Injection.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Tyenne - Tocilizumab-aazg Concentrate 400 mg / 20mL Injection 20 mL, NDC 65219-0594-20, is a Fresenius Kabi USA, LLC 400 mg / 20mL injection presentation packaged as 1 Vial, Single-Dose.

NDC search formats

Canonical NDC 11: 65219-0594-20
Digits-only NDC 11: 65219059420
Possible 10-digit display format: 65219-594-20 (6521959420)

Helpful product links

Search by brand name: Tyenne
NDC 11: 65219-0594-20
Product family NDC: 65219-0594
VA classification code: MS190
VA classification code description: ANTIRHEUMATICS,OTHER
CMOP ID: T1167
VUID: 4043095